Clinical Dynamix
The Executive Director CMC/ Pharmaceutical Development will lead all CMC strategic and operational activities for drug substance and drug product from preclinical through manufacturing, overseeing supply chain, process development, and regulatory filings. Reporting to the CEO, this role manages CMO relationships, technology transfer, and global regulatory submissions to support clinical programs and commercial supply.
Clinical Dynamix matches exceptional talent with cutting-edge companies focused in: Pharmaceutical, Biotechnology, Medical Device/Diagnostics & Gene Therapy
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Clinical Dynamix.
Clinical Dynamix didn’t post a salary, so this is our estimate from similar listings.
5% above the average for this role